India to test its first indigenous COVID-19 vaccine

COVAXIN, India’s first indigenous COVID-19 vaccine, to undergo human clinical trials. It was developed by Hyderabad based Bharat Biotech in collaboration with ICMR and NIV. Pre-clinical studies of the vaccine deemed it safe for use. Phase I and Phase II trials will be conducted soon.

Leave a Reply

Your email address will not be published. Required fields are marked *